STAA (Staar Surgical Co) Cash per Share : $4.50 (As of Mar. 2025)

View and export this data going back to 1983. Start your Free Trial

What is Staar Surgical Co Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Staar Surgical Co's Cash per Share for the quarter that ended in Mar. 2025 was $4.50.

Staar Surgical Co Cash per Share Historical Data

The historical data trend for Staar Surgical Co's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Staar Surgical Co Cash per Share Chart

Staar Surgical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash per Share

Get a 7-Day Free Trial

3.28

4.19

4.39

4.52

4.68

Staar Surgical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash per Share	Get a 7-Day Free Trial															5.02	4.78	4.79	4.68	4.50

Staar Surgical Co Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Staar Surgical Co's Cash per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	230.494	/	49.3
	=	4.68

Staar Surgical Co's Cash per Share for the quarter that ended in Mar. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	222.761	/	49.5
	=	4.50

Staar Surgical Co (NAS:STAA) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Staar Surgical Co Cash per Share Related Terms

Thank you for viewing the detailed overview of Staar Surgical Co's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Staar Surgical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Staar Surgical Co (NAS:STAA) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

SR3:Germany

Address

25510 Commercentre Drive, Lake Forest, CA, USA, 92630

Website

https://www.staar.com

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.

Executives

Broadwood Partners Lp	10 percent owner	BROADWOOD CAPITAL INC., 142 WEST 57TH STREET, 11TH FLOOR, NEW YORK NY 10019
Aimee S Weisner	director	ONE EDWARDS WAY, IRVINE CA 92614
Elizabeth Yeu Lin	director	25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
Warren Foust	officer: Chief Operating Officer	17 MAGNOLIA DRIVE, LADERA RANCH CA 92694
Magda Michna	officer: Chief Clinical, Regulatory,	C/O PRESBIA, 8845 IRVINE CENTER DRIVE, SUITE 100, IRVINE CA 92618
Keith Holliday	officer: V.P., Research & Development	1911 WALKER AVENUE, MONROVIA CA 91016
Robert Studholme	officer: Senior VP, Operations	25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630
James E Francese	officer: VP, Global Marketing	1911 WALKER AVE, MONROVIA CA 91016
Caren L Mason	director	2523 PARK RIDGE DRIVE, ESCONDIDO CA 92025
Samuel J Gesten	officer: VP, General Counsel	1911 WALKER AVENUE, MONROVIA CA 91016
Patrick F. Williams	officer: Chief Financial Officer	C/O ZELTIQ AESTHETICS INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588
Hans-martin Blickensdoerfer	officer: VP, International Marketing	1911 WALKER AVENUE, MONROVIA CA 91016
Lou Silverman	director
Graydon C. Hansen	officer: Sr. VP, Global Operations	25651 ATLANTIC OCEAN DRIVE, LAKE FORST CA 92630
Jon K. Hayashida	officer: VP, Global Clinical, Medical	25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA 92630